Prevention and management of infectious complications in patients with chronic lymphocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current guidelines. - Mikulska M; Oltolini C; Zappulo E; Bartoletti M; Frustaci AM; Visentin A; Vitale C; Mauro FR (Blood reviews, 2024)